A Study to Learn About Revaccination With a Vaccine Called RSVpreF in Immunocompromised Adults

Part of paid clinical trials in Los Angeles, California.

Sponsor
Pfizer
Study ID
NCT07768345
Phase
PHASE3
Status
Recruiting
Apply to this trial

Conditions

  • Respiratory Syncytial Virus (RSV)

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • RSVpreF Vaccine — BIOLOGICAL
    RSVpreF Vaccine

Study Details

The purpose of this phase 3 study is to learn the safety, tolerability and immunogenicity of revaccination with RSVpreF at approximately 1-, 2-, and 3-year intervals to inform the revaccination interval in immunocompromised adults. This study is seeking participants who are 18 years of age and older and will be grouped based on prior RSV vaccination history. Participants are required to be immunocompromised per study protocol. All participants in this study will receive 1 shot to their arm of a RSVPreF vaccine. Participants will take part in this study for about 12 months and will need to visit the clinical study site at least 4 times.

Key Dates

First listed
Aug 17, 2026
Start date
Aug 31, 2026
Status verified
Sep 2026
Primary completion
Feb 2, 2028
Completion
Feb 2, 2028

Study Design

Enrollment
440 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION

Arms

  • Experimental: Group 1
    RSVpreF Vaccine
  • Experimental: Group 2
    RSVpreF Vaccine
  • Experimental: Group 3
    RSVpreF Vaccine
  • Experimental: Group 4
    RSVpreF Vaccine

Primary Outcome Measure

Percentage of participants reporting local reactions [ Time Frame: For up to 7 days after vaccination ]

Central Contacts

Locations (5)

FacilityCityStateZIPSite coordinators
Kaiser Foundation Hospital LAMCLos AngelesCalifornia90027-
Kaiser PermanenteLos AngelesCalifornia90027-
Kaiser Permanente Los Angeles Medical centerLos AngelesCalifornia90027-
The Hope Clinic of Emory UniversityDecaturGeorgia30030-
Rochester Clinical ResearchRochesterNew York14609-

Find similar trials in Los Angeles, CA

By research site
Kaiser Foundation Hospital LAMC· Los Angeles, CAKaiser Permanente· Los Angeles, CAKaiser Permanente Los Angeles Medical center· Los Angeles, CAThe Hope Clinic of Emory University· Decatur, GARochester Clinical Research· Rochester, NY

Related Studies